Welcome to HIV-ASSIST

HIV-ASSIST is a free, interactive, educational tool to inform clinical decision making for ARV selection.

How It Works

HIV-ASSIST integrates current guidelines with relevant patient factors to provide a personalized list of ARV regimens to inform clinical care.

Read about the Development and Validation of HIV-ASSIST in JAIDS 2019.

 Read more

Educational Resources

HIV-ASSIST provides educational resources to support evidence-based care, including ARV all-in-one information sheets, dosing information, drug interactions, and OI prophylaxis guidance.

 

More Info

Get CME Credits

Learn more about how you can obtain Continuing Medical Education (CME) Credits through our partner Decera while using HIV-ASSIST.

We encourage you to consider this CME program: Firm Foundations in HIV Screening, Prevention, and Treatment Virtual Office Hours | Decera Clinical Education

 

Learn More

Read a shared case

Submitted by ahaines8 on
Our study recruits participants who qualify for CAP/RPV based on pre-screening evidence. The goal of the study is to optimize drug regimens for adolescents and young adults, and to gauge interest in… Read full case
Submitted by maunank on
test
Submitted by PreethiMol on
RVD - diagnosed in 2017 - failed first line - - multiple defaults while on TenvirEM, EFV - VL not suppressed after restarting same regime since April 2019 - HIV drug resistance test 23/9… Read full case
Submitted by DR MATIN AHMAD KHAN on
Here the patient is on DRV/r twice plus FTC/TDF and have wide spread mutations against RT, Protease Integrase and even Entry inhibitor gp41.  What best would be to be included for this patient ?… Read full case
Submitted by DR MATIN AHMAD KHAN on
A 40 year comes for followp with virologically suppressed with RPV/TAF/FTC . he is started now  pantaprazole  for reflux oesophagitis and also being given Budesonide /Formetrol  for… Read full case
Submitted by sholzma1 on
I have a 43 year old man with CKD (stage IV, prior Cr ~3), treated HCV and HIV (on Biktarvy) who presented after a year w/o follow-up and found to have progressive renal failure, Cr 11. Admitted for… Read full case
Submitted by Ncwhelan3 on
27 year old female not taking ART's for the last 5 months. The last ART Genvoya caused excessive nausea. She was well controlled on Bictegravir prior however developed apraxia of speech and… Read full case
Submitted by maunank on
40 year old patient with HIV, treatment experienced (prior history of TDF/FTC+RAL, TDF/FTC+RAL+ATVc), off ART for > 1 year, current genotype without resistance (but history of M184V and T97A),… Read full case
Submitted by maunank on
40 year old patient with HIV, treatment experienced (prior history of TDF/FTC+RAL, TDF/FTC+RAL+ATVc), off ART for > 1 year, current genotype without resistance (but history of M184V and T97A),… Read full case
Submitted by MatthewHamill on
59yr old AA man. HIV since at least 2004.  - On Dar/c and Descovy consistently for 13 months. New onset of renal dysfunction - creat 2.1; eGFR 39 (Jan 2021).  Previous creats 1.1 - 1.4… Read full case

Using HIV-ASSIST

Notice: Use of HIV-ASSIST indicates that you agree to our Terms of Use. Recommendations for HIV care and treatment change rapidly, and HIV-ASSIST may not represent up-to-date clinical practice guidelines. HIV-ASSIST rankings are based on one set of expert opinions and scientific literature and may not represent all practice patterns for HIV. HIV-ASSIST has been critically evaluated in several studies, detailed here. Healthcare professionals are encouraged to consult other sources to confirm the information presented on this site.